Loading

For Covifor Availability Hospital Details.. Click Here

For more details on favivir .. Click Here

Our Toll Free Number 18001034696

COVID Drug Launch Excellence Award to Hetero Healthcare
COVID Drug Launch Excellence Award to Hetero Healthcare
Express pharma Excellence award is one of the most prestigious awards for the industry leading pharmaceutical companies. This year’s annual program was conducted on 20th August on E-platform.
Hetero Launches Generic COVID-19 Treatment Drug Favipiravir in India under brand name FAVIVIR
Hetero Launches Generic COVID-19 Treatment Drug Favipiravir in India under brand name FAVIVIR
After Covifor Injection, Hetero developed the second drug 'Favipiravir' for treatment of mild to moderate Coronavirus symptoms following the approvals from the Drug Controller General of India (DCGI) to manufacture and market the generic drug unde
Remdesivir Reason For Hope In Covid-19 Treatment
Remdesivir Reason For Hope In Covid-19 Treatment
Mr. M. Srinivas Reddy, Managing Director of Hetero Healthcare Limited says, Remdesivir Reason For Hope In Covid-19 Treatment.
Annual International Reward Ceremony - Singapore
Annual International Reward Ceremony - Singapore
The third Annual International Award Ceremony was celebrated in Singapore by 275 people that included 125 qualifiers and their family members.
Mumbai Western Kris Division QTR 3 Residential Meeting
Mumbai Western Kris Division QTR 3 Residential Meeting
Mumbai W Region enjoying QTR 3 Residential meeting at Sai River Resort in Nov 19. Team was fully charged for 2 days wherein day 1 was full of reward earning for QTR 1 & 2 followed by DJ and Gala Dinner. Night was sparkling with Talent show
Infrastructure

Hetero Health Care R & D Centre had developed across a vast area. A striking feature of Hetero Health care is the well-planned and comprehensive infrastructure provided

Research & Development

One of the world leaders in developing and manufacturing a wide range of brands/non-brands generics including oncology and ARV drugs

Achievements

Basic manufacturer of Oseltamivir (sub-licencing agreement with Hoffmann-La Rosche, Switzerland) Launched biosimilar Rituximab for treatment of chronic leukaemia

Innovation Drives Progress

When it comes to innovation in the development of new drugs and therapeutic biological products company is completely focused structuring the Molecule need of the industry Innovation Strategy.

Doctors
Formulation Products
+
Field Force

Hetero Healthcare - Innovative Pharmaceutical Company

We aim to improve the quality life of the people with our product line and along with a continuous Research and Development process. To be Recognized as an Innovative Pharmaceutical Company satisfying needs of the Customers, Doctors and Chemists .